Patent: 6,376,242
✉ Email this page to a colleague
Summary for Patent: 6,376,242
Title: | Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
Abstract: | The invention relates to the treatment of subjects for the purpose inhibiting vaso-occlusive events, including thrombosis and embolism, by administering agents which reduce the number of circulating platelets to low or below normal levels. Methods and pharmaceutical preparations comprising such agents are provided. |
Inventor(s): | Hanson; Stephen R. (Stone Mountain, GA) |
Assignee: | Emory University (Atlanta, GA) |
Application Number: | 09/666,224 |
Patent Claims: | see list of patent claims |
Details for Patent 6,376,242
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2039-02-26 |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 12/22/1994 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |